Menu Search

United States

S&P 500Last 5 days
Last price6,920.93
Dow Jones Industrial AverageLast 5 days
Last price48,996.08
NASDAQ CompositeLast 5 days
Last price23,584.28
Bloomberg Commodity IndexLast 5 days
Last price111.72
NYSE CompLast 5 days
Last price22,341.23
FTSE All-World $Last 5 days
Last price679.49
Dow Jones Total Stock MarketLast 5 days
Last price68,442.39
FT Wilshire 5000 IndexLast 5 days
Last price69,171.05
MSCI International ACWI Net Index USLast 5 days
Last price567.16

Loading...

USD overview

PairLatest rateToday's change1 year change
USDGBP0.7427
GBP		-0.0003 / -0.04%--
USDEUR0.8564
EUR		-0.0001 / -0.01%--
USDJPY156.71
JPY		-0.05 / -0.03%--
USDAUD1.49
AUD		-0.0003 / -0.02%--
USDCAD1.39
CAD		-0.0007 / -0.05%--
USDCNY7.00
CNY		0.00 / 0.00%--
USDCHF0.7975
CHF		-0.0003 / -0.04%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of United States in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the S&P 500 with the highest percent gain over one day.
ListingLastChangeVolume
Intel CorpINTC:NSQ42.63
USD		+2.59
+6.47%		165.67m
Regeneron Pharmaceuticals IncREGN:NSQ812.27
USD		+35.73
+4.60%		1.26m
CrowdStrike Holdings IncCRWD:NSQ478.91
USD		+20.59
+4.49%		3.96m
Palo Alto Networks IncPANW:NSQ193.90
USD		+8.04
+4.33%		7.61m
AbbVie IncABBV:NYQ233.42
USD		+9.49
+4.24%		10.28m
Bristol-Myers Squibb CoBMY:NYQ56.72
USD		+2.30
+4.23%		18.03m
Eli Lilly and CoLLY:NYQ1,108.09
USD		+44.05
+4.14%		4.65m
Incyte CorpINCY:NSQ110.57
USD		+3.91
+3.67%		3.38m
Amgen IncAMGN:NSQ341.64
USD		+11.47
+3.47%		3.60m
Vertex Pharmaceuticals IncVRTX:NSQ484.15
USD		+15.77
+3.37%		1.72m
Data delayed at least 15 minutes, as of Jan 07 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.